Trial Profile
A prospective study evaluating efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin in egyptian adolescents with chronic hepatitis C virus Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2017 New trial record